Condition: Mitral Regurgitation · Sponsor: Tioga Cardiovascular, Inc.
The study is aimed to assess the safety and feasibility of the Tioga TMVR System in treating patients with symptomatic MR (MR\>=3+)
This description comes directly from the study's public registry record.
Mariam Maghribi · 510-705-2569 · mariam@tiogamed.com
Tom Kelly · 510-304-1117 · tkelly@tiogamed.com
Always discuss trial participation with your own doctor first.
| Incor - Instituto do Coração do Hospital das Clínicas da FMUSP | São Paulo, Brazil | Recruiting |
| Helsicore Hospital (Israeli Georgeian Medical Research Clinic Healthycore) | Tbilisi, Georgia | Recruiting |
| Tbilisi Heart and Vascular Clinic | Tbilisi, Georgia | Recruiting |
| Vilnius Univ. Hospital | Vilnius, Lithuania | Recruiting |
| Sanatorio Italiano | Asunción, Paraguay | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06038838